glp-1 agonis New Guidelines for Type 2 Diabetes in 2025 Discovery of GLP-1–Based Drugs for

A careful but direct response to a public critiquelaying out the data on statins and GLP-1, a conspicuous omission, and what scientific integrity demands when evidence gets uncomfortable...

Following a GLP-1 diet

Losing weight can pose a challenge, but how to avoid putting those pounds back on can be a real struggle

This article examines the growing prevalence of pediatric obesity and its connection to metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescents, focusing on the role of glucagon-like peptide-1 receptor agonists ...

Whether its Ozempic, Wegovy, or Tirzepatide, these medications are